Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection
This century’s most serious catastrophe, COVID-19, has been dubbed “the most life-threatening disaster ever”. Asthmatic persons are even more prone to COVID-19’s complex interplay with the underlying inflammatory condition. In order to protect themselves against COVID-19, asthmatic patients must be...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2023-03-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2023-0002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832545295601238016 |
|---|---|
| author | Lu Dongming Yaqoob Obaid Kumar Manish Kushwah Ajay Singh Sharma Rahul Kumar Kumar Devinder Mavai Yogendra Khan Rukaiya |
| author_facet | Lu Dongming Yaqoob Obaid Kumar Manish Kushwah Ajay Singh Sharma Rahul Kumar Kumar Devinder Mavai Yogendra Khan Rukaiya |
| author_sort | Lu Dongming |
| collection | DOAJ |
| description | This century’s most serious catastrophe, COVID-19, has been dubbed “the most life-threatening disaster ever”. Asthmatic persons are even more prone to COVID-19’s complex interplay with the underlying inflammatory condition. In order to protect themselves against COVID-19, asthmatic patients must be very vigilant in their usage of therapeutic techniques and drugs (e.g., bronchodilators, 5-lipoxygenase inhibitors), which may be accessed to deal with mild, moderate, and severe COVID-19 indications. People with asthma may have more severe COVID-19 symptoms, which may lead to a worsening of their condition. Several cytokines were found to be elevated in the bronchial tracts of patients with acute instances of COVID-19, suggesting that this ailment may aggravate asthma episodes by increasing inflammation. The intensity of COVID-19 symptoms is lessened in patients with asthma who have superior levels of T-cells. Several antibiotics, antivirals, antipyretics, and anti-inflammatory drugs have been suggested to suppress COVID-19 symptoms in asthmatic persons. Furthermore, smokers are more likely to have aggravated repercussions in COVID-19 infection. Being hospitalized to critical care due to COVID-19, needing mechanical breathing, and suffering from serious health repercussions, are all possible outcomes for someone who has previously smoked. Smoking damages airways and alveoli, which significantly raises the risk of COVID-19-related health complications. Patients with a previous record of smoking are predisposed to severe COVID-19 disease symptoms that essentially require a combination of bronchodilators, mucolytics, antivirals, and antimuscarinic drugs, to cope with the situation. The present review discusses the care and management of asthmatic and smoker patients in COVID-19 infection. |
| format | Article |
| id | doaj-art-3c36ee230c054c37943a477a43349588 |
| institution | Kabale University |
| issn | 1846-9558 |
| language | English |
| publishDate | 2023-03-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Acta Pharmaceutica |
| spelling | doaj-art-3c36ee230c054c37943a477a433495882025-02-03T07:26:16ZengSciendoActa Pharmaceutica1846-95582023-03-01731294210.2478/acph-2023-0002Intensive critical care and management of asthmatic and smoker patients in COVID-19 infectionLu Dongming0Yaqoob Obaid1Kumar Manish2Kushwah Ajay Singh3Sharma Rahul Kumar4Kumar Devinder5Mavai Yogendra6Khan Rukaiya7Department of Pulmonary and Critical Care Medicine, Jinling Hospital Nanjing University School of Medicine Nanjing, Jiangsu, 210000, ChinaDepartment of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (An Autonomous College), Ropar, Punjab 140111, IndiaChitkara College of Pharmacy, Chitkara University, Punjab, 140401, IndiaDepartment of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (An Autonomous College), Ropar, Punjab 140111, IndiaDepartment of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (An Autonomous College), Ropar, Punjab 140111, IndiaDepartment of Pharmacology, Amar Shaheed Baba Ajit Singh Jujhar Singh Memorial College of Pharmacy, Bela (An Autonomous College), Ropar, Punjab 140111, IndiaIPS College of Pharmacy, Shivpuri Link Road Gwalior, M.P., 474001, IndiaAbhilashi College of Pharmacy, Nerchowk Mandi, H.P., 175008, IndiaThis century’s most serious catastrophe, COVID-19, has been dubbed “the most life-threatening disaster ever”. Asthmatic persons are even more prone to COVID-19’s complex interplay with the underlying inflammatory condition. In order to protect themselves against COVID-19, asthmatic patients must be very vigilant in their usage of therapeutic techniques and drugs (e.g., bronchodilators, 5-lipoxygenase inhibitors), which may be accessed to deal with mild, moderate, and severe COVID-19 indications. People with asthma may have more severe COVID-19 symptoms, which may lead to a worsening of their condition. Several cytokines were found to be elevated in the bronchial tracts of patients with acute instances of COVID-19, suggesting that this ailment may aggravate asthma episodes by increasing inflammation. The intensity of COVID-19 symptoms is lessened in patients with asthma who have superior levels of T-cells. Several antibiotics, antivirals, antipyretics, and anti-inflammatory drugs have been suggested to suppress COVID-19 symptoms in asthmatic persons. Furthermore, smokers are more likely to have aggravated repercussions in COVID-19 infection. Being hospitalized to critical care due to COVID-19, needing mechanical breathing, and suffering from serious health repercussions, are all possible outcomes for someone who has previously smoked. Smoking damages airways and alveoli, which significantly raises the risk of COVID-19-related health complications. Patients with a previous record of smoking are predisposed to severe COVID-19 disease symptoms that essentially require a combination of bronchodilators, mucolytics, antivirals, and antimuscarinic drugs, to cope with the situation. The present review discusses the care and management of asthmatic and smoker patients in COVID-19 infection.https://doi.org/10.2478/acph-2023-0002covid-19asthmasmokingcritical caresars-cov-2 |
| spellingShingle | Lu Dongming Yaqoob Obaid Kumar Manish Kushwah Ajay Singh Sharma Rahul Kumar Kumar Devinder Mavai Yogendra Khan Rukaiya Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection Acta Pharmaceutica covid-19 asthma smoking critical care sars-cov-2 |
| title | Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection |
| title_full | Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection |
| title_fullStr | Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection |
| title_full_unstemmed | Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection |
| title_short | Intensive critical care and management of asthmatic and smoker patients in COVID-19 infection |
| title_sort | intensive critical care and management of asthmatic and smoker patients in covid 19 infection |
| topic | covid-19 asthma smoking critical care sars-cov-2 |
| url | https://doi.org/10.2478/acph-2023-0002 |
| work_keys_str_mv | AT ludongming intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT yaqoobobaid intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT kumarmanish intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT kushwahajaysingh intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT sharmarahulkumar intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT kumardevinder intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT mavaiyogendra intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection AT khanrukaiya intensivecriticalcareandmanagementofasthmaticandsmokerpatientsincovid19infection |